Suicide clinical trials

Explore recruiting suicide clinical trials.

Recruiting suicide studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Suicide trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Randomized, Double-blind, Placebo‑controlled Single- and Multiple‑dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VX‑670 in Adult Subjects with Myotonic Dystrophy Type 1

Netherlands, Spain, Belgium, France, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-blind, Randomized, Psychoactive Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine 84 mg in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder in Adolescent Participants with Acute Suicidal Ideation or Behavior

Italy, Hungary, Spain, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)

Germany, Netherlands, France

Phase II and Phase III (Integrated) EU CTIS Study details

REVERSE: a randomized controlled trial (RCT) to ameliorate treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) antagonism

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS)

Poland, Slovakia

Phase II and Phase III (Integrated) EU CTIS Study details

Suicide trials by city

Suicide in Toronto Suicide in Vancouver Suicide in Montreal Suicide in Calgary Suicide in Edmonton Suicide in Ottawa Suicide in Winnipeg Suicide in Quebec City Suicide in Hamilton Suicide in Kitchener Suicide in London Suicide in Halifax Suicide in New York Suicide in Los Angeles Suicide in Chicago Suicide in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease